Spotlight on the
news
of the Cimi

Publications

T-independent responses to polysaccharides in humans mobilize marginal zone B cells prediversified against gut bacterial antigens

01 February 2023

A novel CIMI collaboration underlines the key role played by the immune/microbiota interface in the pre-education of the human antibody repertoire.

The news of the cimi

Team’s FRM 2022 – G Gorochov

10 January 2023

Guy Gorochov’s team has been awarded the Equipe FRM 2022 label for the project «Study and manipulation of host-microbiota mutualism regulated by immunoglobulin A»

Ciminaires Logo Cimi Paris

“Exploring the microbiome to displace multi-drug resistant Enterobacteria from the gut”

Vendredi 14 Octobre à 12h
Location : 91 Bld de l'hopital - Salle 511 Speaker : Dr. Till Strowig
Ciminaires Logo Cimi Paris

« Identification of key components of proteostasis regulation for diagnosis and targeting of inflammatory diseases and cancer »

Lundi 26 Septembre à 12h
Location : 91 Bld de l'hopital - Salle 616 Speaker : Dr. Manuel Rodriguez
Publications Logo Cimi Paris

“Lower disease activity but higher risk of severe COVID- 19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α”

17 August 2022
Publications Logo Cimi Paris

Trans-cellular tunnels induced by the fungal pathogen Candida albicans facilitate invasion through successive epithelial cells without host damage

07 July 2022

Trans-cellular tunnels induced by the fungal pathogen Candida albicans facilitate invasion through successive epithelial cells without host damage.

Ciminaires Logo Cimi Paris

« Malaria, asplenia : a story of sensing, swelling, sickling & pitting »

Location : webminar Speaker : Pierre Buffet
Ciminaires Logo Cimi Paris

« Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses »

Location : webminar Speaker : Dr. Mélanie Bruchard
The news of the cimi Logo Cimi Paris

The effectiveness of a vaccine against #HIV

29 October 2021

Dr behazine combadière, a lead investigator at the centre for immunology and infectious diseases @inserm is working on predicting the effectiveness of a vaccine against #hiv which is concurrently advancing the #covidvaccine development research.

The news of the cimi Logo Cimi Paris

Vaccine responses against SARS-CoV-2 variants examined in people with lupus

08 October 2021

The majority of people with systemic lupus erythematosus (SLE) who respond to messenger (m)RNA COVID-19 vaccines also generate an antibody response against emerging SARS-CoV-2 variants, albeit with reduced neutralizing activity against variants bearing the E484K mutation, researchers report.